Biographical Sketches of Course Directors and Presenting
Faculty (M - Z)
HUSSEINI K. MANJI, M.D., F.R.C.P.C.
Chief, Laboratory of Molecular Pathophysiology
National Institute of Mental Health
Bethesda, Maryland
Husseini K. Manji, M.D. is Chief, Laboratory of Molecular Pathophysiology,
NIMH. Dr. Manji received his B.S. (Biochemistry) and M.D. from the University of
British Columbia. Following psychiatry residency training, he subsequently
completed fellowship training in psychopharmacology at the NIMH and undertook
extensive additional training in Cellular and Molecular Biology at the NIDDK.
The major focus of his ongoing research is the investigation of disease- and
treatment-induced changes in gene and protein expression profiles that regulate
neuroplasticity and cellular resilience in mood disorders. In broad terms, his
laboratories’ scientific goals are to capitalize upon recent insights into our
understanding of the signaling pathways mediating the effects of mood
stabilizers, in order to understand the pathophysiology of severe mood disorders
and to develop improved therapeutics. He has received ongoing research funding
from the NIH, Private Foundations, and pharmaceutical industry for his work on
signaling pathways, gene expression and new medication development for severe
mood disorders.
Dr. Manji is a previous recipient of the A. E. Bennett Award for
Neuropsychiatric Research, the 1999 Ziskind-Somerfeld Award for Neuropsychiatric
Research, the 1999 NARSAD Mood Disorders Prize (Nola Maddox Falcone Prize), the
NIMH award for excellence in clinical care and research, the 2002 NIMH Mentor of
the year award, the NARSAD Independent Investigator Award, the Canadian
Association of Professors in Psychiatry Award, and a Visiting Professor
lectureship to the Salpetreire Hospital, Paris. He has published extensively on
the molecular and cellular mechanisms of action of mood-stabilizing agents, and
has edited a book on the mechanisms of action of antibipolar treatments.
He is a councilor for the Collegium Internationale
neuro-psychopharmacologicum (CINP), a member of both the Canadian College of
Neuropsychopharmacology and the American College of Neuropsychopharmacology (ACNP),
and co-chair on the use of animals in psychopharmacology Committee of the ACNP.
He is chair of the ACNP Task Force on Medication Development, NIMH Bipolar
Initiative Scientific Advisory Board, is a member of the National Alliance for
Research in Schizophrenia and Affective Disorders (NARSAD) Scientific Advisory
Committee, National Alliance for the Mentally Ill (NAMI) Center on Practice &
Research Advisory Committee, the Child and Adolescent Bipolar Foundation
Professional Advisory Council, the Scientific Advisory Board of the Juvenile
Bipolar Research Foundation and the Stanley Medical Research Institute
Scientific Advisory Board. Dr. Manji has also served as a member of the National
Board of Medical Examiners Behavioral Science Test Committee, and the USMLE Step
1 Test Material Development Committee for Behavioral Science, and is the
Director of the NIH Foundation for the Advanced Education in the Sciences
Graduate Course in the Neurobiology of Mental Illness, and co-chair, of the
preclinical models workgroup of the NIMH Strategic Plan for mood disorders. Dr.
Manji is currently editor of Neuroscience Perspectives, Biological Psychiatry,
associate editor of the journal Bipolar Disorders, and sits on the Editorial
Board of the official journal of the CINP.
LAUREN B. MARANGELL, M.D.
Brown Foundation Professor of Psychopharmacology
of Mood Disorders
Department of Psychiatry
Baylor College of Medicine
Houston, Texas
Lauren B. Marangell, MD, graduated from Baylor College of Medicine in 1987
and completed her internship, residency, and chief residency at Albert Einstein
College of Medicine/Montefiore Medical Center in New York. She then spent three
years at the National Institute of Mental Health, as a Fellow and Senior Staff
Fellow, specializing in clinical research, psychopharmacology and mood
disorders.
In 1994, Dr. Marangell joined the faculty of Baylor College of Medicine,
where she is Director of Clinical Psychopharmacology, and Director of Mood
Disorders Research in the Department of Psychiatry. She was recently appointed
as the Brown Foundation Endowed Chair in Psychopharmacology. She has received
numerous awards including the Laughlin Fellowship of the American College of
Psychiatrists, the Young Investigators Award from the National Alliance for
Research in Schizophrenia and Affective Disorders, the Exemplary Psychiatrist
Award from the National Alliance for the Mentally Ill, and the McKnight
Neuroscience of Brain Disorders Award
In addition to contributing numerous articles to the scientific literature,
she is lead author of the Concise Guide to Psychopharmacology, published by The
American Psychiatric Press Inc., in 2002.
DAVID MIKLOWITZ, Ph.D.
Professor of Psychology
University of Colorado
Boulder, Colorado
David Miklowitz, PhD, did his undergraduate work at Brandeis University and
his doctoral (1979 to 1985) and postdoctoral work (1985 to 1988) at UCLA. He has
been on the psychology faculty at the University of Colorado in Boulder since
1989. His research focuses on family environmental factors and family
psychoeducational treatments for adult-onset and childhood-onset bipolar
disorder.
Dr. Miklowitz has received the Joseph Gengerelli Dissertation Award from UCLA
(1986), Young Investigator Awards from the International Congress on
Schizophrenia Research (1987) and the National Alliance for Research on
Schizophrenia and Depression (NARSAD; 1987), a Research Faculty Award from the
University of Colorado (1998), and a Distinguished Investigator Award from
NARSAD (2001). He also has received funding for his research from the National
Institute for Mental Health and the John D. and Catherine T. MacArthur
Foundation.
Dr. Miklowitz has published over 100 research articles and book chapters on
bipolar disorder and schizophrenia. His articles have appeared in the Archives
of General Psychiatry, the British Journal of Psychiatry, the Journal of Nervous
and Mental Disease, Biological Psychiatry, the Journal of Consulting and
Clinical Psychology, and the Journal of Abnormal Psychology. His book with
Michael Goldstein, Bipolar Disorder: A Family-Focused Treatment Approach
(Guilford), won the 1998 Outstanding Research Publication Award from the
American Association of Marital and Family Therapy. His latest book, also with
Guilford, is titled The Bipolar Disorder Survival Guide.
PHILIP MITCHELL M.B., B.S., M.D., F.R.A.N.Z.C.P., F.R.C.PSYCH.
Professor and Head, School of Psychiatry
University of New South Wales
Sydney, Australia
Philip Mitchell was appointed as Professor in the School of Psychiatry at the
University of New South Wales (UNSW) in January, 1999 and then as Head of School
in May, 2002.
Professor Mitchell graduated with first-class honours in Medicine from the
University of Sydney in 1977. He received his MD by research from UNSW in 1991
for his studies on the neuroendocrinology of depression.
After working at Royal Prince Alfred Hospital in Sydney as a Professorial
Intern, then SRMO, Professor Mitchell commenced postgraduate training in
Psychiatry at the Prince of Wales and Prince Henry Hospitals in 1979. He
continued his professional training in psychiatry in London from 1981 to 1983,
working initially at St Georges’ Hospital then the Bethlem Royal and Maudsley
Hospitals. It was while working in the UK that he first developed his research
interests in mood disorders. On returning to Sydney in late 1983, he first
worked as a Clinical Fellow in Psychiatry at Westmead Hospital. He became a
Fellow of the Royal Australian and New Zealand College of Psychiatrists (RANZCP)
in 1986 and a Fellow of the Royal College of Psychiatrists in 1996.
In 1985 he was offered the position of lecturer in the School of Psychiatry
at UNSW, being subsequently promoted to Senior Lecturer in 1989 and Associated
Professor in 1993. In 1993 he worked for six months as a Guest Researcher in
Psychopharmacology at the National Institute of Mental Health in Bethesda,
Maryland, USA. He was appointed as an honorary Senior Principal Research Fellow
at the Garvan Institute of Medical Research in Sydney in 2001. In 2002 he was
awarded the Organon Senior Research Award of the RANZCP.
Professor Mitchell’s major research interests are in the molecular genetics
of bipolar disorder, pharmacological and psychological treatments of bipolar
disorder and depression, phenomenological and epidemiological aspects of bipolar
disorder, and transcranial magnetic stimulation as a treatment for depression
and other psychiatric illnesses. He is a member of an NHMRC-funded program grant
team studying depression and bipolar disorder.
Professor Mitchell has published (in conjunction with colleagues) over 250
papers or chapters on these topics. He is supervisor or co-supervisor of three
doctoral students, and is on the editorial boards of ‘Psychiatric Genetics’ and
the ‘World Journal of Biological Psychiatry’.
Professor Mitchell is currently President of the Australasian Society for
Psychiatric Research, an associate member of the Australian Drug Evaluation
Committee (ADEC), and serves on the Research Committee of the Australian Rotary
Health Research Fund. He is also a member of the Chapter Professional Advisors
Committee, National Depressive and Manic Depressive Association
(U.S./international).
PAOLO LUCIO MORSELLI, M.D.
Vice President Fondazione IDEA
Vice-President ISBD
and Secretary General of GAMIAN-Europe
Milan, Italy
Paolo Lucio Morselli graduated with honors in Medicine (1961) and specialized
in Psychiatry (1965 cum laude) from the University of Milan, Milan, Italy. He
then spent two years, as a Fullbright-Hays Fellow at the Department of
Biochemical Pharmacology, Medical College of Virginia, Richmond, Virginia, USA.
In 1968 Professor Morselli returned to Italy, where he was appointed Head of the
Clinical Pharmacology Unit at the Mario Negri Institute, Milan. From 1976–1994,
he held a variety of professional posts at Synthélabo Pharmaceutical, Paris,
France, including Executive Director of Clinical Research, Director General for
Medical Affairs and Corporate Vice-President for Clinical Research and
Development. He retired in 1994. He has received several awards for his work
including the “Ambrogino d’oro” from the City of Milano (1972), the “ASPET-ILAE
Research Award” (1978), the “Ambassador for Epilepsy Award” (1979), and the
“Prix-Galien Award” ( Paris-1992). He has been quoted in Marquis “Who is Who in
the World” (1990, 1992 and 2003 eds.). Professor Morselli is a member of several
professional and medical societies, and is on the Editorial Boards of 13
international scientific journals. He has published more than 480 scientific
articles and 20 specialized monographs. Professor Morselli has been “Visiting
Professor” at several French Universities (1980–1992) and at Universidad
Autonoma de Barcelona , España (1991-2000), “Associated Scientist” at “Institut
Philippe Pinel de Montréal,” Canada (1994) and “Professore a contratto” at the
Department of Psychiatry of the University of Pisa, Italy (2000-2002). Professor
Morselli currently serves, on a volunteer “pro bono basis” in two Advocacy
Organization operating in the Mental Health field: as Vice-President of
Fondazione-IDEA in Milan, Italy (1997–present), and as Secretary General of
GAMIAN-Europe (1998–present) where he is also a “charter member”. He is also
serves as Vice-President for ISBD (2001- present).
Present major interests are: social and therapeutic aspects of mood disorders
and more specifically Bipolar Disorder; the problems linked to stigma and
prejudice associated with unipolar depression, Bipolar Disorder and other mental
illnesses; and the role of advocacy associations for mental illnesses in the long term
management of the psychiatric patient.
BRUNO MÜLLER-OERLINGHAUSEN, Dr.med.
Professor em. of Clinical Psychopharmacology
Freie Universität Berlin
Chairman of the Drug Commission of the German Medical Association
Berlin, Germany
Bruno Müller-Oerlinghausen was born in 1936 in Berlin. He obtained his
training in medicine at the universities of Göttingen, Munich, Francfort/M.,
Freiburg, and Berlin (West). 1964 to 1969 he underwent a postgraduate training
in pharmacology and toxicology at the Department of Pharmacology, University of
Goettingen, and qualified as a lecturer in pharmacology and toxicology with a
thesis on “Hormonal influence on mechanisms of hepatic detoxification”. 1969 to
1971 he was assigned to the Department of Medical Sciences (Ministry of Public
Health) in Bangkok (Thailand) by the government of the Federal Republic of
Germany as an expert in pharmacology. He built up a pharmacological research lab
and trained the Thai staff in methods to investigate the pharmacology of
old-style herbal medicine. In 1971 he entered the Department of Psychiatry,
Freie Universität Berlin, for additional training in clinical psychiatry, and in
1974 he was appointed as Chief Scientist of the Lithium Clinic Berlin, and at
the same time promoted to Professor of Clinical Psychopharmacology and Chief of
the Laboratory of Clinical Psychopharmacology. For 27 years he was
editor-in-chief of Pharmacopsychiatry, and he is associate editor of many other
journals, such as Bipolar Disorders, Journal of Psychiatry and Neuroscience or
Drug Research. 1983 to 1987 he was elected as president of AGNP (Association for
Neuropharmacology of the German speaking countries), 1982 to 1988 he served as
Councillor of the Executive Board of CINP. Since 1994 he is the acting chairman
of the Drug Commission of the German Medical Association.
His scientific interests were mainly related to the clinical pharmacology of
antidepressants, neuroleptics and particularly lithium salts in humans. Recent
work focused on long-term effects of lithium salts with special regard to its
serotonergic action including anti-aggressive and antisuicidal effects;
serotonergic mechanisms in patients with affective disorders; genetic studies in
depression and in clozapine-induced agranulocytosis.
MICHAEL W. OTTO, PH.D.
Director, Cognitive-Behavior Therapy Program
Massachusetts General Hospital (MGH)
Associate Professor of Psychology
Department of Psychiatry, Harvard Medical School
Boston, Massachusetts
Dr. Otto specializes in the cognitive-behavioral treatment of anxiety and
mood disorders, and has developed clinical-research programs at MGH for the
treatment of panic disorder, posttraumatic stress disorder, social phobia,
bipolar disorder, psychotic disorders, substance dependence, and medication
discontinuation in patients with panic disorder. Dr. Otto's research activities
are closely tied to his clinical interests and target investigations of the
etiology and treatment of anxiety, affective, and substance-use disorders. Of
particular interest to Dr. Otto is the development and testing of new
treatments, including the combination of pharmacologic and cognitive-behavioral
strategies for treatment-refractory and substance abusing patients, and the
modification of treatment packages for novel populations (e.g., Cambodian
refugees). He has published over 150 articles, book chapters, and books spanning
these research interests. His books include Challenges in Clinical Practice:
Pharmacologic and Psychosocial Strategies, co-edited with Drs. Pollack and
Rosenbaum, and the Stopping Anxiety Medication treatment manuals for patients
and therapists. Dr. Otto is a fellow of the American Psychological Association,
directs fellowship and internship training in cognitive-behavior therapy at MGH,
and has been a regular provider of continuing education and continuing medical
education workshops across the United States and abroad. He also serves as a
section editor for Cognitive and Behavioral Practice, and on the editorial
boards of Behavior Research and Therapy, Clinical Psychology: Science and
Practice, Journal of Anxiety Disorders, Journal Watch in Psychiatry, and
Psychotherapy and Psychosomatics.
PAMELA B. PEELE, Ph.D.
Assistant Professor of Health Economics
Graduate School of Public Health
University of Pittsburgh
Pittsburgh, Pennsylvania
Dr. Pamela Peele is an Associate Professor of Health Economics in Health
Policy & Management and Psychiatry. She received her undergraduate training in
economics at Roanoke College in Salem, Virginia and her Masters and Ph.D. in
economics from Virginia Polytechnic Institute and State University. Her formal
economics training is in industrial organization and game theory. She is a
Registered Electroencephalographic Technologist. She is Core Faculty at the
Center for Research on Health Care at the University of Pittsburgh. She serves
on the Advisory Board for the Center for Injury Research and Control at the
University of Pittsburgh and on the Advisory Board for Business Administration
and Economics at Roanoke College.
Dr. Peele’s research focuses on work and health. She has multiple projects
and publications related to financing and delivery of mental health care as well
as occupational research focused on the health of workers, including the
influence of depression on occupational injury. Her work includes partnerships
with public and private corporations and has been recognized by the Association
of Schools of Public Health as outstanding collaboration between academia and
practice.
Dr. Peele teaches a graduate course in health economics in the Graduate
School of Public Health that applies game theory to health care markets. She is
the recipient of several teaching awards. She also lectures frequently on
medical, occupational, and mental health care financing. She is ad hoc reviewer
for the National Science Foundation, the Whitaker Foundation, and the National
Institute of Occupational Safety and Health. She presents annual workshops in
game theory for the National Math/Science Foundation aimed at keeping 12-15 year
old girls interested in math and science. She is a member of various
professional organizations, including the Committee on the Status of Women in
the Economics Profession and is an elected member of Delta Omega honor society
in Public Health. She is listed in Who’s Who in America.
NOREEN A. REILLY-HARRINGTON, Ph.D.
Instructor in Psychology
Harvard Medical School
Clinical Assistant in Psychology
Massachusetts General Hospital
Department of Psychiatry
Boston, Massachusetts
Noreen A. Reilly-Harrington, Ph.D. is an Instructor in Psychology at Harvard
Medical School and is on the staff of the Harvard Bipolar Research Program at
Massachusetts General Hospital. She is a graduate of University of Pennsylvania
and Temple University and completed her internship and post-doctoral fellowship
at Massachusetts General Hospital and Harvard Medical School. Dr.
Reilly-Harrington is a Founding Fellow of the Academy of Cognitive Therapy and
has received research awards from the Society for Research in Psychopathology,
the Association for the Advancement of Behavior Therapy, and Massachusetts
General Hospital for her work examining the role of life stress and cognition on
the course of bipolar mood disorders. She has lectured both nationally and
internationally on the topic of cognitive therapy for bipolar disorder and has
recently co-authored a book entitled “Bipolar Disorder: A Cognitive Therapy
Approach” published by the American Psychological Association. She currently
serves as a Psychosocial Pathway Leader and Clinical/Scientific Coordinator for
the National Institute of Mental Health's Systematic Treatment Enhancement
Program for Bipolar Disorder, the largest study of bipolar disorder ever
conducted. Dr. Reilly-Harrington is the recipient of a NIMH Small Business
Innovative Research grant designed to improve rater reliability through the use
of innovative technology. She is also involved in studies examining
neuropsychological functioning in bipolar disorder and cognitive-behavioral
treatment for rapid cycling bipolar disorder.
ALESSANDRO ROTONDO, M.D.
Researcher
Department of Psychiatry, Neurobiology, Pharmacology, and Biotechnology
University of Pisa
Pisa, Italy
Dr. Rotondo received his medical training in Italy at the University of Pisa.
He completed his psychiatric residency at the Department of Psychiatry,
Neurobiology, Pharmacology, and Biotechnology (DPNPB) of the University of Pisa
and his training in neurogenetics at the Laboratory of Neurogenetics of the
National Institute on Alcohol Abuse and Alcoholism/National Institutes of
Health, Rockville, MD. Since 1997 he has been on the faculty at the University
of Pisa, in the DPNPB. Currently he is a researcher at the DPNPB.
Dr. Rotondo has done research in neurochemistry of neuroreceptors
(particularly serotonin) and their involvement in the pathophysiology of mood
and anxiety disorders. In the last eight years, his research has focused on
genetic association studies, mainly on the association of candidate genes with
mood disorders, eating disorders, and self-harm behavior. He is the author of
about thirty publications in international journals.
Dr. Rotondo is the recipient of research project grants from the Italian
government on the genetics of mood disorders and eating disorders, as well as on
the pharmacogenetics of antidepressant and atypical antipsychotics. He also
participates in international collaborative studies on the genetics of eating
disorders and panic disorder.
GARY S. SACHS, M.D.
Associate Professor in Psychiatry
Harvard Medical School
Director, Bipolar Mood Disorder Program
Massachusetts General Hospital
Gary S. Sachs, M.D., is Associate Professor in Psychiatry at Harvard Medical
School; Clinical Assistant in Psychiatry and Director, Bipolar Mood Disorder
Program, at Massachusetts General Hospital; Director, Harvard Bipolar Research
Program; and Director, Partners Bipolar Treatment Center. Dr. Sachs earned his
medical degree at the University of Maryland School of Medicine. He interned in
family practice and psychiatry at University of Maryland Hospital in Baltimore,
was a resident in psychiatry and Chief Resident, Acute Psychiatry Service, at
Massachusetts General Hospital in Boston.
Dr. Sachs is the Principal Investigator of the NIMH Systematic Treatment
Enhancement Program for Bipolar Disorder. He serves on the scientific advisory
board of the National Depression and Manic Depression Association and is
Co-editor-in-chief of Clinical Approaches to Bipolar Disorder and on numerous
editorial boards. Dr. Sachs has authored over 150 articles, abstracts, books,
reviews, and book chapters.
JAN SCOTT, M.D., FRCPsych.
Professor of Psychological Treatments Research
Institute of Psychiatry, Decrespigny Park
London, United Kingdom
Jan Scott, M.D., FRCPsych is now Professor of Psychological Treatments
Research, at the Institute of Psychiatry in London. Her clinical work is focused
on the treatment of individuals with chronic and severe affective disorders. Her
research focuses on development of psychobiosocial models of mood disorders and
exploring the benefits of combined pharmacological and psychological treatment
strategies. Professor Scott is the principal investigator on the Medical
Research Council multi-centre randomized controlled trial of cognitive therapy
for bipolar affective disorders. She has over 250 publications in psychiatry and
a number of books including one written for individuals with bipolar disorder
called ‘Overcoming Mood Swings’.
Previous clinical posts include training in cognitive therapy with Professor
Aaron T. Beck in Philadelphia, USA. She was awarded the Royal College of
Psychiatrists Travelling Fellowship to undertake clinical and research training
in Madison, Wisconsin and Johns Hopkins University in Baltimore. Professor Scott
is a member of a number of national and international committees; is a former
Sub-Dean of the Royal College of Psychiatrists, UK; the immediate Past President
of the British Association for Behavioural & Cognitive Psychotherapy; an
assistant editor of the British Journal of Psychiatry, the Journal of Mental
Health and Psychotherapy and Psychosomatics; and the vice-chair of the Mental
Health and Neurosciences Board of the Medical research Council in the UK. She is
a professional adviser to the Manic Depression Fellowship of Britain and was
made a Distinguished Founding Fellow of the International Academy of Cognitive
Therapy (one of 8 individuals worldwide).
KENNETH I. SHULMAN, M.D.
Professor, Department of Psychiatry
Sunnybrook & Women’s College Health Sciences Centre
University of Toronto
Toronto, Ontario
Dr. Shulman graduated from the Faculty of Medicine, University of Toronto in
1973 and did postgraduate training in Psychiatry at the University of Toronto.
He then went on to do specialty training in Geriatric Psychiatry in London,
England. Since 1978, he has been based at Sunnybrook & Women’s in Toronto where
he has been involved in the development of a comprehensive geriatric psychiatry
service and academic program. In 1990, he completed a Master of Science in
Health Policy and Management at the Harvard School of Public Health.
Dr. Shulman was formerly the Director of the Division of Geriatric Psychiatry
at the University of Toronto and Foundation Director of the Interdepartmental
Division of Geriatrics for the Faculty of Medicine. For ten years he served as
Psychiatrist-in-Chief at Sunnybrook & Women’s and Vice-Chair, Clinical Affairs
of the University of Toronto, Department of Psychiatry. In 2001 he joined the
Board of Directors of the International Psychogeriatric Association. He is the
inaugural recipient of the Richard Lewar Chair in Geriatric Psychiatry at
Sunnybrook & Women’s, University of Toronto.
Academic interests include mania and bipolarity in old age; the clock drawing
test and brief cognitive screening; mental health policy; and testamentary
capacity.
GREGORY SIMON, M.D., M.P.H.
Senior Investigator
Center for Health Studies
Group Health Cooperative
Seattle, Washington
Dr. Simon received his MD degree from the University of North Carolina
followed by residency training in internal medicine at the University of
Washington, residency training in psychiatry at Massachusetts General Hospital,
and fellowship training in the Robert Wood Johnson Clinical Scholars Program at
the University of Washington. Since 1990 he has been an investigator at the
Center for Health Studies of Group Health Cooperative and has practiced adult
Psychiatry in Group Health’s Behavioral Health Service.
Dr. Simon’s research has focused on the epidemiology and management of mood
disorders in both primary care and psychiatric practice. Specific research
topics have included: epidemiology of mental disorders in primary care, economic
burden of mood and anxiety disorders, interventions to improve depression
management in primary care, cost-effectiveness of treatments for mood disorders,
psychotherapy for depression and bipolar disorder, relative effectiveness of
different antidepressant and mood stabilizer drugs, and suicide risk in
depression and bipolar disorder.
Dr. Simon has published approximately 150 scientific articles and book
chapters, and serves on the editorial boards of several psychiatric and general
medical journals. He also serves on the national advisory board of the
Depression and Bipolar Support Alliance. In 2002 he received the Senior Scholar
Award for Health Services Research from the American Psychiatric Association.
Dr. Simon continues to practice outpatient psychiatry approximately half-time
with a focus on treatment-resistant depression and bipolar disorder.
HOLLY A. SWARTZ, M.D.
Assistant Professor of Psychiatry
University of Pittsburgh School of Medicine
Depression and Manic-Depression Prevention Program
Western Psychiatric Institute and Clinic
Pittsburgh, Pennsylvania
Dr. Swartz received a bachelor’s degree from Harvard University in Cambridge,
Massachusetts and her medical degree from the Albert Einstein College of
Medicine in the Bronx, New York. She completed her psychiatric residency at
Payne Whitney Clinic-New York Hospital in New York City, and she joined the
faculty of the Department of Psychiatry at the University of Pittsburgh Medical
School in 1997. She is currently an attending psychiatrist at the Depression and
Manic-Depression Prevention Program of Western Psychiatric Institute and Clinic
and a recipient of a Mentored Patient-Oriented Research Career Development grant
from the National Institute of Mental Health.
Dr. Swartz’s research focuses on the development and evaluation of
psychosocial interventions for the treatment of mood disorder. She is
specifically interested in optimizing interventions for women with mood
disorders and adapting psychotherapies for difficult-to-treat populations. She
is currently conducting a trial of brief psychotherapy for depressed mothers
whose children also suffer from a psychiatric disorder. She is a co-investigator
for the Maintenance Therapies in Bipolar Disorder study at the University of
Pittsburgh and has a longstanding interest in the role of psychotherapy in the
management of bipolar disorder.
Dr. Swartz has been the recipient of a Reader’s Digest Research Fellowship
from Cornell University Medical College and a Junior Faculty Scholar Award from
the University of Pittsburgh Department of Psychiatry. She received a Golden
Apple Award nomination for her excellence in teaching psychiatry residents, and
a 2003 NCDEU New Investigator Award. Dr. Swartz is a member of a number of
professional societies, including the American Psychiatric Association, the
Society for Psychotherapy Research, the International Society for Interpersonal
Psychotherapy, and the International Society for Bipolar Disorders. She serves
as an ad hoc reviewer for Bipolar Disorders. Dr. Swartz has presented her work
at numerous local, national, and international workshops, conferences and
scientific meetings.
MICHAEL E. THASE, M.D.
Professor of Psychiatry
University of Pittsburgh School of Medicine
Western Psychiatric Institute and Clinic
Pittsburgh, Pennsylvania
Michael E. Thase, M.D., is a Professor of Psychiatry at the University of
Pittsburgh School of Medicine and the Western Psychiatric Institute and Clinic.
He is an active clinical investigator, whose research focuses on the assessment
and treatment of mood disorders, including the correlates of differential
response to various treatments for depression. A 1979 graduate of the Ohio State
University College of Medicine, Dr. Thase has directed the Depression Treatment
and Research Program at the University of Pittsburgh since its inception in 1987
and is now the Chief of Adult Academic Psychiatry. A Fellow of the American
Psychiatric Association, Dr. Thase has authored or co-authored over 350
scientific articles and book chapters, as well as 8 books.
MAURICIO TOHEN, M.D., Dr. P.H.
Lilly Clinical Research Fellow, Lilly Research Laboratories
Eli Lilly and Company
Associate Clinical Professor Psychiatry
Harvard Medical School
Indianapolis, Indiana
Mauricio Tohen, M.D., Dr.P.H., graduated as a doctor of medicine from the
National University of Mexico in 1976 and as a doctor of public health
(epidemiology) from Harvard University in 1988. His postdoctoral training
included a residency in psychiatry at the University of Toronto (1979 - 1982)
and a fellowship at McLean Hospital, Harvard Medical School (1982 - 1985). From
1988 to 1997, he was clinical director of the Bipolar and Psychotic Disorder
Program at McLean Hospital. In 1997, he joined Lilly Research Laboratories where
he is currently a Lilly Clinical Research Fellow and Medical Director of the
Zyprexa Product Team. He is also an Associate Clinical Professor of Psychiatry
at Harvard Medical School.
He received a National Service Award in Psychiatric Epidemiology from NIMH
and Harvard University. He also received a FIRST award from NIMH, the Pope Award
from McLean Hospital, and a NARSAD Young Investigator Award. Dr. Tohen’s
research, supported by grants from NIMH and the pharmaceutical industry, has
focused on the epidemiology, outcome, and treatment of bipolar disorder.
He has served on the Council on Research and the committee on Health Services
Research of the American Psychiatric Association. He has also served in the
Epidemiology & Genetics and the Clinical Centers and Special Projects Review
committees at NIMH. Dr. Tohen has over 100 publications. He co-edited two books,
Psychiatric Epidemiology (1995) and Mood Disorders Across the Life Span (1996).
He also edited the book Comorbidity in Affective Disorders (1999).
LEONARDO TONDO, M.D.
Department of Psychology
University of Cagliari
Director
Centro Lucio Bini
Cagliari, Italy
Leonardo Tondo, M.D., M.S., completed his medical education at the University
of Rome, graduating summa cum laude. In 1977, he became the founding director of
the Centro Lucio Bini in Cagliari, Sardinia, that was included in the Stanley
Medical Research Institute Research Program in 1998. From 1980 to 2000, he was
an assistant professor at the University of Cagliari, and since 2000, he has
been Associate Professor in General Psychology at the Department of Psychology
of Cagliari University. In 1980, Dr. Tondo was a visiting scientist at Johns
Hopkins University. In 1983, he was a lecturer at the University of
Pennsylvania; and in 1986 he was a researcher at UCLA. Since 1994, he has been
associated with the Department of Psychiatry at Harvard University and the
McLean Hospital. His main research topics are the course of bipolar disorders,
treatment with lithium, and medical prevention of suicide. He has received
research awards from NARSAD and the Stanley Foundation since 1995. In 2003, he
received a Master of Science in Epidemiology from the Harvard School of Public
Health. Dr. Tondo is the author of more than one hundred international
publications.
PER VESTERGAARD, Dr.Med.Sc.
Professor of Psychiatry Aarhus University Aarhus University Psychiatric
Hospital Risskov, Denmark
Dr. Vestergaard is Professor of Clinical Psychiatry of Aarhus University,
Denmark. He is also Director of Clinical Research, and Chief of Clinical
Outpatient Services at the University Psychiatric Hospital. He founded the Mood
Disorder Research Unit and the Lithium Clinic of the Aarhus Psychiatric
Hospital. He has conducted research and published articles on the clinical
pharmacology of lithium, on the treatment efficacy of old and new antidepressant
drugs, on affective disorders in general and bipolar disorder in particular. He
was a co-founder of the Danish University Antidepressant Group (DUAG). He has
published textbooks on psychiatry and psychopharmacology and is an editorial
consultant on several psychiatric journals. Dr. Vestergaard is a recipient of
Stanley Institute Grants.
EDUARD VIETA, M.D., PH.D.
Director of the Bipolar Disorder Program
Hospital Clinic
University of Barcelona
Barcelona, Spain
Eduard Vieta is currently Director of Research and Director of the Bipolar
Disorders Program of the Hospital Clinic at the University of Barcelona, Spain.
He also serves as Postgraduate Professor of Psychopharmacology and Affective
Disorders at the University. He has authored over 100 original articles, 21 book
chapters and 9 complete books on bipolar disorder.
ADELE C. VIGUERA, M.D.
Assistant Professor of Psychiatry
Harvard Medical School
Associate Director of the Perinatal and Reproductive Psychiatry Program
Massachusetts General Hospital
Boston, Massachusetts
Adele C. Viguera, M.D., is the associate director of the Perinatal and
Reproductive Psychiatry Program at Massachusetts General Hospital and an
Assistant Professor of Psychiatry at Harvard Medical School in Boston,
Massachusetts. Dr. Viguera received her MD from Dartmouth Medical School in
Hanover, New Hampshire, and served her internship and residency at Massachusetts
General Hospital and McLean Hospital in Belmont, Massachusetts.
The recipient of several honors and awards, Dr. Viguera is a recent recipient
of an NIMH sponsored K23 Mentored Patient-Oriented Research Career Development
Award as well as a NARSAD Young Investigators Award for her project on neonatal
outcome following exposure to Lithium: What Happens to Lithium Babies? Her
current research interests include the course and treatment of bipolar mood
disorders during pregnancy and the postpartum period and the effects of prenatal
lithium exposure on infant development.
Dr. Viguera’s research, teaching and clinical activities focus on women’s
mental health, specifically psychiatric disorders across the female reproductive
life-cycle. Her area of particular interest are major mood disorders associated
with pregnancy and the postpartum period. Dr. Viguera’s additional clinical
activities include outpatient evaluation, consultation and clinical follow-up in
both the Perinatal & Reproductive Psychiatry Program and the Obstetrics and
Gynecology Outpatient Department at the Massachusetts General Hospital. She
performs diagnostic and psychopharmacologic consultation on pregnant and
postpartum women with major mood disorders. Her work has been published in a
number of scientific journals and books.
ROBERT M. WETTSTEIN, M.D.
Clinical Professor of Psychiatry
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania
Dr. Wettstein is in the private practice of psychiatry, with an emphasis on
legal and ethical practice issues. He is a consultant to the state licensing
boards in medicine, psychology, nursing, dentistry, chiropractic, and law, and
evaluates impaired professionals. He also conducts independent examinations
regarding disability, workers compensation, and criminal responsibility.
Between 1984 and 1996, Dr. Wettstein was on the full-time faculty at WPIC,
and was codirector of the Law and Psychiatry Program. He was involved in
clinical consultations, treatment, and research activities in the law and
psychiatry area. In 1996, he was awarded the “Golden Apple” award for excellence
in teaching by the residents of WPIC.
Dr. Wettstein was Editor of the quarterly journal Behavioral Sciences and the
Law until 1996. He is coauthor with Barbara Weiner, Esq. of Legal Issues in
Mental Health Care. His edited volume, Treatment of Offenders with Mental
Disorders, was published in 1998. He is also author of many other publications
on legal and ethical issues in mental health care.
He is the President-Elect of the American Academy of Psychiatry and the Law.
LAKSHMI N. YATHAM, M.B., F.R.C.P.C.
Michael Smith Foundation Senior Scholar Associate Professor of Psychiatry
Director, Mood Disorders
Clinical Research Unit
University of British Columbia
Vancouver, British Columbia, Canada
Lakshmi N. Yatham, MB, FRCPC, is Associate Professor of Psychiatry and
Director of the Mood Disorders Clinical Research Unit at the University of
British Columbia in Vancouver. His major areas of research interest include
neurobiology and treatment of bipolar disorder and major depression. Dr. Yatham
is a recipient of the Michael Smith Foundation Senior Scholar Award, and his
work has been funded by a number of peer-reviewed funding agencies such as the
Canadian Institutes of Health Research (CIHR), Canadian Psychiatric Research
Foundation, Stanley Foundation, and National Alliance for Research on
Schizophrenia and Depression, USA. Dr. Yatham leads a Canadian consortium on
bipolar disorder, which is currently pursuing development and testing of new and
innovative treatments for bipolar disorder under his direction with substantial
funding from CIHR.
Dr. Yatham co-led the development of Canadian guidelines for treatment of
bipolar disorder. He is Chair of the bipolar group of the Canadian Network for
Mood and Anxiety Treatments (CANMAT), and is actively involved at a national and
international level in continuing medical education and public education on
diagnosis and treatment of bipolar disorder for psychiatrists, family
physicians, and the general public. Dr. Yatham is the Secretary/Treasurer for
International Society on Bipolar Disorders and he is on the editorial boards of
a number of journals including Bipolar Disorders, Brain Pharmacology, and Human
Psychopharmacology. He has published over 100 papers in peer-reviewed
international journals and presented his research work at numerous international
conferences.
ALLAN H. YOUNG, M.D., Ph.D.
Professor of Psychiatry
School of Neuroscience and Psychiatry
University of Newcastle
Royal Victoria Infirmary
Newcastle upon Tyne, United Kingdom
Professor Allan Young trained in medicine and thereafter psychiatry at the
University of Edinburgh and held a Royal College of Physicians of Edinburgh
training fellowship at the MRC Brain Metabolism Unit. Subsequently, he was a
clinical lecturer at the University of Oxford and worked in the MRC Clinical
Psychopharmacology Unit with Professor Philip Cowen before becoming Senior
Lecturer and Honorary Consultant at the University of Newcastle.
Now Professor of General Psychiatry, Allan Young is also Director of both
Psychiatry and the Stanley Research Centre at the University of Newcastle. He is
a Council Member of the British Association for Psychopharmacology and Secretary
of the Royal College of Psychiatrists’ Psychopharmacology Special Interest
Group, and member of the Scientific Advisory Council of the Stanley Medical
Research Institute.. He has published over 200 scientific publications on the
etiology and treatment of psychiatric disorders, particularly mood disorders.
Top of Page
|
